Your browser doesn't support javascript.
loading
Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist.
Erstad, Derek J; Farrar, Christian T; Ghoshal, Sarani; Masia, Ricard; Ferreira, Diego S; Chen, Yin-Ching Iris; Choi, Ji-Kyung; Wei, Lan; Waghorn, Phillip A; Rotile, Nicholas J; Tu, Chuantao; Graham-O'Regan, Katherine A; Sojoodi, Mozhdeh; Li, Shen; Li, Yang; Wang, Guogiang; Corey, Kathleen E; Or, Yat Sun; Jiang, Lijuan; Tanabe, Kenneth K; Caravan, Peter; Fuchs, Bryan C.
Afiliación
  • Erstad DJ; Division of Surgical Oncology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Farrar CT; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Ghoshal S; Division of Surgical Oncology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Masia R; Department of Pathology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Ferreira DS; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Chen YI; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Choi JK; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Wei L; Division of Surgical Oncology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Waghorn PA; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Rotile NJ; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Tu C; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Graham-O'Regan KA; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Sojoodi M; Division of Surgical Oncology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Li S; Division of Surgical Oncology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Li Y; Enanta Pharmaceuticals Watertown MA.
  • Wang G; Enanta Pharmaceuticals Watertown MA.
  • Corey KE; Department of Medicine, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Or YS; Enanta Pharmaceuticals Watertown MA.
  • Jiang L; Enanta Pharmaceuticals Watertown MA.
  • Tanabe KK; Division of Surgical Oncology, Massachusetts General Hospital Harvard Medical School Boston MA.
  • Caravan P; Martinos Center for Biomedical Imaging, Massachusetts General Hospital Harvard Medical School Charlestown MA.
  • Fuchs BC; Institute for Innovation in Imaging Massachusetts General Hospital Boston MA.
Hepatol Commun ; 2(7): 821-835, 2018 Jul.
Article en En | MEDLINE | ID: mdl-30027140
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepatol Commun Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hepatol Commun Año: 2018 Tipo del documento: Article